According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...

The science is sound and the evidence is clear; immunization plays a crucial role in helping to protect children’s health ...

The respiratory syncytial virus vaccine is effective in reducing emergency visits, hospitalizations, and severe illness in ...

An international team of scientists has found compelling evidence that early-infancy infection with respiratory syncytial ...

Cold and flu season typically happen during the fall and winter. Though it comes around every year, there's still a lot of ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to ...

Pregnant women and adults over 75 among priority groups for RSV protection as respiratory virus season approaches in Ohio.

Flu: An annual flu shot is recommended for all adults. For adults age 65 and older, the CDC recommends one of three specific ...

Respiratory syncytial virus can cause severe illness especially in young infants. A new study published in Eurosurveillance ...

Antar stressed that “what remains of the coronavirus is merely scattered, non-impactful droplets, and no variant of the ...